İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2012 · article

Clinical evaluations of cffDNA quantities in preeclamptic pregnancies

Dergi The Journal of Obstetrics and Gynaecology
YÖKSİS OpenAlex Üst %10
Yıl2012
Atıf25OpenAlex
Yüzdelik%94,6
FWCI5,071,00 = dünya ortalaması

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıThe Journal of Obstetrics and Gynaecology
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

AIM: Quantitative changes of cell-free fetal DNA in maternal plasma as an indicator for impending pre-eclampsia was reported in different studies. Cell-free fetal nucleic acids can be detected in maternal circulation during pregnancy. Our aim was to determine the higher rate of fetal DNA levels in maternal blood in pre-eclampsia compared to normal pregnancies and the clinical use of real-time polymerase chain reaction (PCR) in the Turkish population as a marker. MATERIAL AND METHODS: According to their gestational ages, the plasma levels of 30 pre-eclamptic women at 26-40 weeks of pregnancy were matched with 18 healthy pregnant women. Cell-free fetal DNA levels in maternal plasma were compared using real-time PCR technology. For the quantitative measurement of fetal DNA from maternal blood, the relative quantification PCR process was applied to all samples, using SRY and GAPDH genes. These patients were classified as pre-eclamptic and control groups and were matched according to weeks of pregnancy. RESULTS: Free fetal DNA levels of 30 pre-eclamptic patients were compared to healthy pregnant women and an average 3.06-fold increase was observed. During the second trimester, free fetal DNA levels were 1.5 times higher in pre-eclamptic patients. This increase was 3.5-fold during the third trimester. The DNA increase of pre-eclamptic patients was 4.1-fold and 3.4-fold during 29th-33rd and 34th-40th weeks, respectively. CONCLUSIONS: Cell-free fetal DNA in maternal blood could be used as a marker for identifying subjects at increased risk of developing pre-eclampsia.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

25atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 7 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2015 Genomic and proteomic investigation of preeclampsiaAtıf 13 · OpenAlex
  2. 2015 Genomic and proteomic investigation of preeclampsiaAtıf 13 · OpenAlex
  3. 2015 Genomic and proteomic investigation of preeclampsiaAtıf 13 · OpenAlex
  4. 2014 Current approaches on non invasive prenatal diagnosis Prenatal genomics transcriptomics personalized fetal diagnosisAtıf 5 · OpenAlex
  5. 2014 Current approaches on non-invasive prenatal diagnosis:Prenatal genomics, transcriptomics, personalized fetal diagnosis Non-invasiv prenatal tanida güncel yaklaşımlar: Prenatal genomik, transkriptomik, bireysel fetal tanıAtıf 5 · OpenAlex
  6. 2020 The potential of serum fetal DNA for early diagnosis of gestational trophoblastic diseaseAtıf 1 · OpenAlex
  7. 2017 No increase in free fetal DNA level in ectopic pregnancy: A preliminary studyAtıf 0 · OpenAlex

Yazarlar

5
  1. YOSUN GÖRKEM ZEYBEK 1
  2. TUBA GÜNEL İSTANBUL ÜNİVERSİTESİ 2
  3. ALİ BENİAN İSTANBUL ÜNİVERSİTESİ-CERRAHPAŞA 3
  4. KILIÇ AYDINLI 4
  5. SEMIH KALELI 5